WGS Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 27.30%

Insider Buying (Last 12 Months): $3,771,670.44

Insider Selling (Last 12 Months): $130,491,416.29

GeneDx Insider Trading History Chart

GeneDx Share Price & Price History

^$95.47

▼ -2.81 (-2.86%)

As of 04/17/2025 05:00 PM ET

Days: 30 | 90 | 365

GeneDx Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/9/2025	Katherine Stueland	CEO	Sell	46,594	$89.62	$4,175,754.28	1,720
4/9/2025	Kevin Feeley	CFO	Sell	15,516	$92.18	$1,430,264.88	1,726
3/26/2025	Katherine Stueland	CEO	Sell	46,551	$95.62	$4,451,206.62	48,314
3/26/2025	Kevin Feeley	CFO	Sell	8,746	$95.61	$836,205.06	15,996
3/17/2025	Katherine Stueland	CEO	Sell	10,559	$96.71	$1,021,160.89	14,865
3/17/2025	Kevin Feeley	CFO	Sell	3,749	$96.71	$362,565.79	8,492
3/13/2025	Katherine Stueland	CEO	Sell	1,078	$89.44	$96,416.32	6,674
3/13/2025	Kevin Feeley	CFO	Sell	402	$90.05	$36,200.10	5,044
3/10/2025	Katherine Stueland	CEO	Sell	2,731	$94.73	$258,707.63	7,752
3/10/2025	Kevin Feeley	CFO	Sell	922	$94.72	$87,331.84	5,446
1/29/2025	Katherine Stueland	CEO	Sell	1,657	$78.48	$130,041.36	3,937
1/29/2025	Kevin Feeley	CFO	Sell	275	$78.48	$21,582.00	2,950
1/7/2025	Katherine Stueland	CEO	Sell	51,420	$94.48	$4,858,161.60	1,720
1/7/2025	Kevin Feeley	CFO	Sell	35,506	$93.82	$3,331,172.92	2,472
1/2/2025	Katherine Stueland	CEO	Sell	18,006	$78.18	$1,407,709.08	53,140
1/2/2025	Kevin Feeley	CFO	Sell	1,430	$76.04	$108,737.20	26,770
12/16/2024	Katherine Stueland	CEO	Sell	10,501	$76.75	$805,951.75	71,146
12/16/2024	Kevin Feeley	CFO	Sell	3,728	$76.75	$286,124.00	28,200
12/9/2024	Katherine Stueland	CEO	Sell	3,661	$76.37	$279,590.57	62,897
12/9/2024	Kevin Feeley	CFO	Sell	1,137	$76.37	$86,832.69	24,731
12/2/2024	Kevin Feeley	CFO	Sell	263	$78.39	$20,616.57	23,406
11/21/2024	Kevin Feeley	CFO	Sell	12,019	$73.76	$886,521.44	32,932
11/19/2024	Jason Ryan	Director	Sell	31,510	$71.28	$2,246,032.80	15,490
11/18/2024	Katherine Stueland	CEO	Sell	22,307	$70.34	$1,569,074.38	60,011
11/18/2024	School Of Medicine At Mo Icahn	Major Shareholder	Sell	126,782	$70.78	$8,973,629.96	2,719,692
11/15/2024	Katherine Stueland	CEO	Sell	23,108	$70.48	$1,628,651.84	82,318
11/15/2024	School Of Medicine At Mo Icahn	Major Shareholder	Sell	20,359	$69.78	$1,420,651.02	2,846,474
10/31/2024	School Of Medicine At Mo Icahn	Major Shareholder	Sell	865,800	$75.00	$64,935,000.00	2,866,833
10/29/2024	Katherine Stueland	CEO	Sell	2,154	$66.60	$143,456.40	105,426
10/29/2024	Kevin Feeley	CFO	Sell	274	$66.60	$18,248.40	44,951
9/9/2024	Katherine Stueland	CEO	Sell	3,639	$33.33	$121,287.87	95,457
9/9/2024	Kevin Feeley	CFO	Sell	895	$33.33	$29,830.35	39,910
9/3/2024	Kevin Feeley	CFO	Sell	262	$31.71	$8,308.02	38,343
8/19/2024	Opko Health, Inc.	Major Shareholder	Sell	50,000	$34.49	$1,724,500.00	2,646,972
8/15/2024	Opko Health, Inc.	Major Shareholder	Sell	39,824	$33.08	$1,317,377.92	2,746,972
8/12/2024	Opko Health, Inc.	Major Shareholder	Sell	59,787	$33.95	$2,029,768.65	2,811,783
8/8/2024	Opko Health, Inc.	Major Shareholder	Sell	100,000	$31.82	$3,182,000.00	2,871,570
8/6/2024	Opko Health, Inc.	Major Shareholder	Sell	12,994	$29.35	$381,373.90	2,971,570
7/31/2024	Opko Health, Inc.	Major Shareholder	Sell	88,839	$33.50	$2,976,106.50	2,984,564
7/29/2024	Katherine Stueland	CEO	Sell	2,154	$33.54	$72,245.16	92,550
7/29/2024	Kevin Feeley	CFO	Sell	274	$33.54	$9,189.96	37,888
7/29/2024	Opko Health, Inc.	Major Shareholder	Sell	50,000	$33.86	$1,693,000.00	3,073,403
7/26/2024	Opko Health, Inc.	Major Shareholder	Sell	60,000	$33.85	$2,031,000.00	3,123,403
7/24/2024	Opko Health, Inc.	Major Shareholder	Sell	75,000	$33.72	$2,529,000.00	3,183,403
7/22/2024	Opko Health, Inc.	Major Shareholder	Sell	50,000	$32.61	$1,630,500.00	3,333,403
7/19/2024	Opko Health, Inc.	Major Shareholder	Sell	25,000	$32.29	$807,250.00	3,383,403
7/17/2024	Opko Health, Inc.	Major Shareholder	Sell	25,000	$32.93	$823,250.00	3,408,403
7/5/2024	Opko Health, Inc.	Major Shareholder	Sell	36,118	$28.24	$1,019,972.32	3,433,403
7/3/2024	Opko Health, Inc.	Major Shareholder	Sell	14,082	$28.23	$397,534.86	3,469,521
7/1/2024	Opko Health, Inc.	Major Shareholder	Sell	50,000	$26.63	$1,331,500.00	3,508,603
6/17/2024	Katherine Stueland	CEO	Sell	7,683	$28.31	$217,505.73	90,830
6/17/2024	Kevin Feeley	CFO	Sell	2,646	$28.31	$74,908.26	37,409
6/10/2024	Katherine Stueland	CEO	Sell	2,652	$24.92	$66,087.84	79,763
6/10/2024	Kevin Feeley	CFO	Sell	895	$24.92	$22,303.40	32,858
6/3/2024	Casdin Capital, Llc	Director	Buy	100,000	$20.82	$2,082,000.00	3,063,509
5/28/2024	Casdin Capital, Llc	Director	Buy	18,304	$20.61	$377,245.44	2,923,509
5/23/2024	Casdin Capital, Llc	Director	Buy	7,500	$19.59	$146,925.00	2,761,009
5/13/2024	Casdin Capital, Llc	Director	Buy	50,000	$23.31	$1,165,500.00	2,753,509
4/29/2024	Katherine Stueland	CEO	Sell	6,325	$11.04	$69,828.00	75,869
4/29/2024	Kevin Feeley	CFO	Sell	1,104	$11.04	$12,188.16	30,836
3/18/2024	Kareem Saad	Insider	Sell	2,008	$10.59	$21,264.72	29,517
3/18/2024	Katherine Stueland	CEO	Sell	8,559	$10.59	$90,639.81	66,698
3/18/2024	Kevin Feeley	CFO	Sell	3,253	$10.59	$34,449.27	28,927
3/4/2024	Casdin Capital, Llc	Director	Buy	40,000	$8.74	$349,600.00	2,702,609
1/22/2024	Kareem Saad	Insider	Sell	193	$3.24	$625.32	24,467
1/3/2024	Kareem Saad	Insider	Sell	105	$2.58	$270.90	24,114
12/18/2023	Kareem Saad	Insider	Sell	1,700	$2.16	$3,672.00	23,946
12/18/2023	Katherine Stueland	CEO	Sell	11,734	$2.16	$25,345.44	52,578
12/18/2023	Kevin Feeley	CFO	Sell	2,948	$2.16	$6,367.68	23,035
12/4/2023	Kevin Feeley	CFO	Sell	270	$1.77	$477.90	17,232
11/16/2023	Jason Ryan	Chairman	Buy	56,742	$1.27	$72,062.34	56,742
11/8/2023	Richard C. Pfenniger, Jr.	Director	Buy	10,000	$1.49	$14,900.00	20,918
10/20/2023	Kareem Saad	Insider	Sell	164	$3.44	$564.16	18,541
10/17/2023	Jason Ryan	Chairman	Sell	42	$3.19	$133.98	5,834
10/3/2023	Kareem Saad	Insider	Sell	85	$3.56	$302.60	18,159
9/18/2023	Kareem Saad	Insider	Sell	1,580	$4.16	$6,572.80	17,971
9/18/2023	Katherine Stueland	CEO	Sell	10,752	$4.16	$44,728.32	42,689
9/18/2023	Kevin Feeley	CFO	Sell	2,742	$4.16	$11,406.72	16,785
9/11/2023	Kareem Saad	Insider	Sell	846	$4.62	$3,908.52	14,437
9/11/2023	Katherine Stueland	CEO	Sell	2,675	$4.62	$12,358.50	34,691
9/11/2023	Kevin Feeley	CFO	Sell	904	$4.62	$4,176.48	12,330
9/5/2023	Kevin Feeley	CFO	Sell	269	$4.38	$1,178.22	10,772
8/17/2023	Richard C. Pfenniger, Jr.	Director	Buy	5,000	$5.10	$25,500.00	10,918
7/26/2023	Karen Ann White	Insider	Sell	61	$7.41	$452.01	4,761
7/20/2023	Kareem Saad	Insider	Sell	163	$7.85	$1,279.55	12,442
7/3/2023	Karen Ann White	Insider	Sell	45	$5.99	$269.55	4,685
6/20/2023	Karen Ann White	Insider	Sell	1,549	$6.37	$9,867.13	4,631
6/20/2023	Katherine Stueland	CEO	Sell	7,965	$6.37	$50,737.05	30,819
6/20/2023	Kevin Feeley	CFO	Sell	2,744	$6.37	$17,479.28	10,324
6/13/2023	Kevin Feeley	CFO	Sell	903	$6.49	$5,860.47	5,871
6/12/2023	Karen Ann White	Insider	Sell	828	$6.49	$5,373.72	2,770
6/12/2023	Katherine Stueland	CEO	Sell	2,674	$6.49	$17,354.26	20,034
6/2/2023	Kevin Feeley	CFO	Sell	263	$7.00	$1,841.00	4,312
5/18/2023	Richard C. Pfenniger, Jr.	Director	Buy	5,000	$5.90	$29,500.00	5,918
5/16/2023	Katherine Stueland	CEO	Sell	8,685	$6.50	$56,452.50	16,162
5/16/2023	Kevin Feeley	CFO	Sell	1,516	$6.50	$9,854.00	3,856
4/26/2023	Karen Ann White	Insider	Sell	61	$9.57	$583.77	1,703
4/20/2023	Kareem Saad	Insider	Sell	161	$10.23	$1,647.03	5,979
4/3/2023	Karen Ann White	Insider	Sell	52	$11.22	$583.44	1,627
3/10/2023	Karen Ann White	Insider	Sell	993	$11.88	$11,796.84	1,580
3/10/2023	Katherine Stueland	CEO	Sell	2,807	$11.88	$33,347.16	9,350
3/10/2023	Kevin Feeley	CFO	Sell	965	$11.88	$11,464.20	2,359
1/4/2023	Karen Ann White	Insider	Sell	49	$8.58	$420.42	543
12/2/2022	Kevin Feeley	CFO	Sell	256	$13.20	$3,379.20	460
12/1/2022	Keith A Meister	Director	Sell	205,738	$13.20	$2,715,741.60	610,360
11/28/2022	Katherine Stueland	CEO	Buy	5,611	$17.82	$99,988.02	5,611
10/26/2022	Karen Ann White	Insider	Sell	60	$33.66	$2,019.60	493
10/20/2022	Kareem Saad	Insider	Sell	164	$29.37	$4,816.68	2,906
10/17/2022	Jason Ryan	Chairman	Sell	38	$28.38	$1,078.44	479
10/3/2022	Kareem Saad	Insider	Sell	80	$31.02	$2,481.60	2,525
8/25/2022	Richard Miao	CFO	Sell	105	$39.60	$4,158.00	753
8/9/2022	Isaac Ro	CFO	Sell	613	$65.67	$40,255.71	7,395
7/26/2022	Daniel Emmett Clark	General Counsel	Sell	38	$48.51	$1,843.38	9,460
7/26/2022	Karen Ann White	Insider	Sell	62	$48.51	$3,007.62	361
7/20/2022	Kareem Saad	Insider	Sell	160	$52.80	$8,448.00	2,333
5/20/2022	Eric Schadt	Insider	Buy	3,030	$63.36	$191,980.80	7,375
5/11/2022	Shawn Assad	CAO	Sell	94	$57.75	$5,428.50	972
5/10/2022	Isaac Ro	CFO	Sell	591	$81.18	$47,977.38	6,114
4/29/2022	Keith A Meister	Director	Buy	346,590	$132.00	$45,749,880.00	816,098
4/29/2022	Tactical Opportunit Blackstone	Major Shareholder	Buy	75,757	$132.00	$9,999,924.00	813,308
4/28/2022	Anthony Prentice	Insider	Sell	51	$71.94	$3,668.94	298
4/28/2022	Daniel Emmett Clark	General Counsel	Sell	36	$71.94	$2,589.84	9,380
4/20/2022	Kareem Saad	Insider	Sell	189	$82.17	$15,530.13	1,948

See Full Table

SEC Filings (Institutional Ownership Changes) for GeneDx (NASDAQ:WGS)

61.72% of GeneDx stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

GeneDx Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/15/2025	Assenagon Asset Management S.A.	106,119	$9.40M	0.0%	-60.3%	0.378%
4/15/2025	SG Americas Securities LLC	10,451	$0.93M	0.0%	+19.6%	0.037%
4/15/2025	GAMMA Investing LLC	438	$39K	0.0%	+151.7%	0.002%
4/14/2025	Harbor Capital Advisors Inc.	15,937	$1.41M	0.1%	N/A	0.057%
4/8/2025	Rhumbline Advisers	19,352	$1.71M	0.0%	-2.0%	0.069%
4/7/2025	GAMMA Investing LLC	38,792	$3.44M	0.0%	+22,194.3%	0.138%
3/24/2025	Wellington Management Group LLP	140,792	$10.82M	0.0%	N/A	0.502%
3/18/2025	California State Teachers Retirement System	11,384	$0.88M	0.0%	+13.3%	0.041%
2/25/2025	Polar Asset Management Partners Inc.	13,100	$1.01M	0.0%	N/A	0.048%
2/18/2025	Palisades Investment Partners LLC	83,604	$6.43M	2.7%	N/A	0.304%
2/18/2025	Castleark Management LLC	61,710	$4.74M	0.2%	N/A	0.225%
2/18/2025	PharVision Advisers LLC	3,910	$0.30M	0.3%	N/A	0.014%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	16,849	$1.30M	0.0%	+120.3%	0.061%
2/17/2025	Voloridge Investment Management LLC	221,097	$16.99M	0.1%	-1.5%	0.805%
2/17/2025	Soleus Capital Management L.P.	4,000	$0.31M	0.0%	N/A	0.015%
2/17/2025	Squarepoint Ops LLC	11,989	$0.92M	0.0%	-74.4%	0.044%
2/17/2025	Two Sigma Advisers LP	43,242	$3.32M	0.0%	N/A	0.157%
2/17/2025	Two Sigma Investments LP	152,073	$11.69M	0.0%	+276.3%	0.554%
2/17/2025	Tidal Investments LLC	7,202	$0.55M	0.0%	-40.5%	0.026%
2/17/2025	State of Wyoming	1,249	$96K	0.0%	-62.6%	0.005%
2/17/2025	Summit Partners Public Asset Management LLC	755,564	$58.07M	1.1%	+336.9%	2.750%
2/17/2025	Silvercrest Asset Management Group LLC	71,709	$5.51M	0.0%	N/A	0.261%
2/17/2025	Redwood Investment Management LLC	6,079	$0.47M	0.0%	N/A	0.022%
2/17/2025	Point72 Asset Management L.P.	63,088	$4.85M	0.0%	-78.5%	0.230%
2/17/2025	Polar Asset Management Partners Inc.	13,100	$1.01M	0.0%	N/A	0.048%
2/17/2025	ProShare Advisors LLC	3,598	$0.28M	0.0%	N/A	0.013%
2/17/2025	Panoramic Capital LLC	51,294	$3.94M	2.1%	N/A	0.187%
2/17/2025	Nia Impact Advisors LLC	19,256	$1.48M	0.5%	N/A	0.070%
2/17/2025	Nicholas Investment Partners LP	97,049	$7.46M	0.7%	+40.0%	0.353%
2/17/2025	Nuveen Asset Management LLC	197,365	$15.17M	0.0%	+1.6%	0.718%
2/17/2025	Millennium Management LLC	58,803	$4.52M	0.0%	-89.8%	0.214%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	7,188	$0.55M	0.0%	+7.7%	0.026%
2/17/2025	Lazard Asset Management LLC	457	$35K	0.0%	N/A	0.002%
2/17/2025	Janus Henderson Group PLC	5,600	$0.43M	0.0%	N/A	0.020%
2/17/2025	Gen Wealth Partners Inc	1,055	$81K	0.0%	N/A	0.004%
2/17/2025	Gotham Asset Management LLC	16,587	$1.28M	0.0%	+23.1%	0.060%
2/17/2025	Graham Capital Management L.P.	17,453	$1.34M	0.0%	+38.7%	0.064%
2/17/2025	Ensign Peak Advisors Inc	26,900	$2.07M	0.0%	N/A	0.098%
2/17/2025	Farallon Capital Management LLC	195,000	$14.99M	0.1%	N/A	0.710%
2/17/2025	Fred Alger Management LLC	546,054	$41.97M	0.2%	+38.5%	1.988%
2/17/2025	Deutsche Bank AG	10,375	$0.80M	0.0%	-91.6%	0.038%
2/17/2025	Driehaus Capital Management LLC	324,918	$24.97M	0.2%	-31.3%	1.183%
2/17/2025	Divisadero Street Capital Management LP	288,240	$22.15M	2.6%	+29.9%	1.049%
2/17/2025	Bosun Asset Management LLC	117,274	$9.01M	3.9%	-31.1%	0.427%
2/17/2025	Bank of America Corp DE	24,402	$1.88M	0.0%	-40.4%	0.089%
2/17/2025	BNP Paribas Financial Markets	56,588	$4.35M	0.0%	N/A	0.206%
2/17/2025	Ameriprise Financial Inc.	34,407	$2.65M	0.0%	N/A	0.125%
2/17/2025	Algert Global LLC	42,926	$3.30M	0.1%	-35.1%	0.156%
2/14/2025	Oracle Investment Management Inc.	1,023,468	$78.66M	42.8%	-2.1%	3.726%
2/14/2025	Freestone Grove Partners LP	5,791	$0.45M	0.0%	N/A	0.021%
2/14/2025	Comerica Bank	649	$50K	0.0%	N/A	0.002%
2/14/2025	Regal Partners Ltd	10,000	$0.77M	0.1%	N/A	0.036%
2/14/2025	AQR Capital Management LLC	57,531	$4.42M	0.0%	-34.2%	0.209%
2/14/2025	Emerald Mutual Fund Advisers Trust	57,637	$4.43M	0.3%	N/A	0.210%
2/14/2025	Northern Trust Corp	179,651	$13.81M	0.0%	+19.7%	0.654%
2/14/2025	Tudor Investment Corp ET AL	101,810	$7.83M	0.0%	+67.7%	0.371%
2/14/2025	Quarry LP	1,017	$78K	0.0%	N/A	0.004%
2/14/2025	Tri Locum Partners LP	127,567	$9.81M	2.0%	N/A	0.464%
2/14/2025	Aquatic Capital Management LLC	4,867	$0.37M	0.0%	N/A	0.018%
2/14/2025	Nebula Research & Development LLC	4,918	$0.38M	0.0%	N/A	0.018%
2/14/2025	Lord Abbett & CO. LLC	630,473	$48.46M	0.2%	N/A	2.295%
2/14/2025	Oberweis Asset Management Inc.	123,500	$9.49M	0.4%	+1.2%	0.450%
2/14/2025	Science & Technology Partners L.P.	401,000	$30.82M	9.4%	N/A	1.460%
2/14/2025	Voya Investment Management LLC	3,798	$0.29M	0.0%	N/A	0.014%
2/14/2025	RiverPark Advisors LLC	3,031	$0.23M	0.2%	N/A	0.011%
2/14/2025	Price T Rowe Associates Inc. MD	66,968	$5.15M	0.0%	+5.3%	0.244%
2/14/2025	MetLife Investment Management LLC	7,750	$0.60M	0.0%	+6.2%	0.028%
2/14/2025	Dimensional Fund Advisors LP	14,054	$1.08M	0.0%	N/A	0.051%
2/14/2025	Alpha DNA Investment Management LLC	5,238	$0.40M	0.2%	-48.8%	0.019%
2/13/2025	Canada Pension Plan Investment Board	88,000	$6.76M	0.0%	+131.6%	0.320%
2/13/2025	EAM Investors LLC	51,183	$3.93M	0.6%	+56.3%	0.186%
2/13/2025	Barclays PLC	80,407	$6.18M	0.0%	+325.0%	0.293%
2/13/2025	Next Century Growth Investors LLC	312,014	$23.98M	1.8%	+121.1%	1.136%
2/13/2025	Sterling Capital Management LLC	352	$27K	0.0%	+877.8%	0.001%
2/13/2025	F M Investments LLC	7,469	$0.57M	0.0%	N/A	0.027%
2/13/2025	Raymond James Financial Inc.	265,045	$20.37M	0.0%	N/A	0.965%
2/13/2025	Renaissance Technologies LLC	205,116	$15.77M	0.0%	+119.2%	0.747%
2/13/2025	Legal & General Group Plc	11,123	$0.86M	0.0%	+31.1%	0.040%
2/13/2025	Invesco Ltd.	255,351	$19.63M	0.0%	+4,382.2%	0.930%
2/13/2025	Russell Investments Group Ltd.	105,413	$8.10M	0.0%	-41.6%	0.384%
2/13/2025	Envestnet Asset Management Inc.	4,941	$0.38M	0.0%	N/A	0.018%
2/13/2025	Wells Fargo & Company MN	8,382	$0.64M	0.0%	+42.0%	0.031%
2/13/2025	Integrated Quantitative Investments LLC	4,700	$0.36M	0.2%	N/A	0.017%
2/12/2025	Thoroughbred Financial Services LLC	5,250	$0.40M	0.0%	N/A	0.019%
2/12/2025	Trexquant Investment LP	74,912	$5.76M	0.1%	-38.6%	0.273%
2/12/2025	Geode Capital Management LLC	382,350	$29.40M	0.0%	+1.2%	1.392%
2/12/2025	National Bank of Canada FI	45,000	$3.46M	0.0%	N/A	0.164%
2/12/2025	Alliancebernstein L.P.	13,850	$1.07M	0.0%	+74.2%	0.050%
2/12/2025	Wellington Management Group LLP	140,792	$10.82M	0.0%	N/A	0.513%
2/12/2025	Pictet Asset Management Holding SA	2,886	$0.22M	0.0%	N/A	0.011%
2/12/2025	Norges Bank	68,000	$5.23M	0.0%	N/A	0.248%
2/12/2025	JPMorgan Chase & Co.	107,891	$8.29M	0.0%	+106.8%	0.393%
2/11/2025	EntryPoint Capital LLC	12,141	$0.93M	0.4%	+32.1%	0.044%
2/11/2025	Prudential Financial Inc.	103,275	$7.94M	0.0%	N/A	0.376%
2/11/2025	Corebridge Financial Inc.	6,352	$0.49M	0.0%	-5.2%	0.023%
2/11/2025	Emerald Advisers LLC	91,818	$7.06M	0.3%	N/A	0.334%
2/11/2025	Vanguard Group Inc.	1,006,210	$77.34M	0.0%	+18.5%	3.663%
2/11/2025	LPL Financial LLC	35,621	$2.74M	0.0%	N/A	0.130%
2/11/2025	KLP Kapitalforvaltning AS	2,600	$0.20M	0.0%	N/A	0.009%
2/11/2025	Sei Investments Co.	18,012	$1.38M	0.0%	N/A	0.066%

Data available starting January 2016

See Full Table

GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.

Today's Range

Now: $95.47

$92.92

$97.78

50 Day Range

MA: $93.79

$70.97

$112.76

52 Week Range

Now: $95.47

$9.33

$115.60

Volume

621,673 shs

Average Volume

682,724 shs

Market Capitalization

$2.68 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.93

Who are the company insiders with the largest holdings of GeneDx?: GeneDx's top insider shareholders include:
Opko Health, Inc (Major Shareholder)
Casdin Capital, Llc (Director)
School Of Medicine At Mo Icahn (Major Shareholder)
Katherine Stueland (CEO)
Jason Ryan (Chairman)
Kevin Feeley (CFO)
Kareem Saad (Insider)
Richard C Pfenniger Jr (Director)
Jason Ryan (Director)
Karen Ann White (Insider)
Learn More about top insider investors at GeneDx.
Who are the major institutional investors of GeneDx?: GeneDx's top institutional shareholders include:
Assenagon Asset Management S.A. — 0.38%
GAMMA Investing LLC — 0.14%
Rhumbline Advisers — 0.07%
Harbor Capital Advisors Inc. — 0.06%
SG Americas Securities LLC — 0.04%
GAMMA Investing LLC — 0.00%
Learn More about top institutional investors of GeneDx stock.
Which major investors are selling GeneDx stock?: During the last quarter, WGS stock was sold by these institutional investors:
Assenagon Asset Management S.A.
Rhumbline Advisers
In the last year, company insiders that have sold GeneDx company stock include:
Opko Health, Inc (Major Shareholder)
Casdin Capital, Llc (Director)
School Of Medicine At Mo Icahn (Major Shareholder)
Katherine Stueland (CEO)
Jason Ryan (Chairman)
Learn More investors selling GeneDx stock.
Which major investors are buying GeneDx stock?: In the last quarter, WGS stock was bought by institutional investors including:
GAMMA Investing LLC
Harbor Capital Advisors Inc.
SG Americas Securities LLC
GAMMA Investing LLC
During the previous year, these company insiders have bought GeneDx stock:
Opko Health, Inc (Major Shareholder)
Casdin Capital, Llc (Director)
School Of Medicine At Mo Icahn (Major Shareholder)
Learn More investors buying GeneDx stock.